Market Overview

ContraVir Says SEC Filing Made In Error, Stock Moves Down


ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) said Friday that its recent registration withdrawal was filed in error.

The ContraVir Pharma "RW" filing was made Thursday. The SEC RW filing is made by companies requesting to formally withdraw a pending securities registration.

ContraVir shares were down 10.98% at $9 at the time of publication Friday. 

Related Links:

Why Low-Float, Thinly Traded ContraVir Pharma's Rally Is Continuing

Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates


Related Articles (CTRV)

View Comments and Join the Discussion!

Posted-In: Biotech News General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at